SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-298872
Filing Date
2022-12-06
Accepted
2022-12-06 07:02:43
Documents
9

Document Format Files

Seq Description Document Type Size
1 425 d348600d425.htm 425 67185
2 GRAPHIC g348600ex99_2s1g1.jpg GRAPHIC 416606
3 GRAPHIC g348600ex99_2s2g1.jpg GRAPHIC 873647
4 GRAPHIC g348600ex99_2s3g1.jpg GRAPHIC 489554
5 GRAPHIC g348600ex99_2s4g1.jpg GRAPHIC 462081
6 GRAPHIC g348600ex99_2s5g1.jpg GRAPHIC 337274
7 GRAPHIC g348600ex99_2s6g1.jpg GRAPHIC 436640
8 GRAPHIC g348600ex99_2s7g1.jpg GRAPHIC 338255
9 GRAPHIC g348600snap4.jpg GRAPHIC 9793
  Complete submission text file 0001193125-22-298872.txt   4703078
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filed by) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Subject) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-38692 | Film No.: 221446680
SIC: 2834 Pharmaceutical Preparations